Odevixibat by Ipsen for Biliary Atresia: Likelihood of Approval

Odevixibat is under clinical development by Ipsen and currently in Phase III for Biliary Atresia.

Preparing Healthcare Providers for the Psychedelic Therapy Shift

The acceptance of cannabis has been a monumental decision within the United States. Not only has it produced an industry of its own, but it’s

September 5, 2023

New study shows dramatic health benefits of quitting smoking

People who quit smoking see major gains in life expectancy after just a few years, according to a new study by University of Toronto researchers

February 10, 2024

Baylor wins 2024 STAT Madness with ‘smoke alarm’ for viral disease outbreaks

It began with injecting monkeys with sewage to see if they developed polio. Building off that early polio work from the 1940s, researchers from the

April 5, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.